Insmed
INSM
#542
Rank
$43.50 B
Marketcap
$204.00
Share price
-0.51%
Change (1 day)
170.81%
Change (1 year)

Insmed (INSM) - Total debt

Total debt on the balance sheet as of September 2025 : $0.57 Billion USD

According to Insmed's latest financial reports the company's total debt is $0.57 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Insmed - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$1.14 B-4.58%
2023-12-31$1.20 B2.22%
2022-12-31$1.17 B92.38%
2021-12-31$0.61 B51.24%
2020-12-31$0.40 B1.97%
2019-12-31$0.39 B25.42%
2018-12-31$0.31 B469.69%
2017-12-31$55.56 M1.42%
2016-12-31$54.79 M117.94%
2015-12-31$25.14 M1.14%
2014-12-31$24.85 M26.27%
2013-12-31$19.68 M1.53%
2012-12-31$19.38 M6824.29%
2011-12-31$0.28 M70.73%
2010-12-31$0.16 M-21.15%
2009-12-31$0.2 M-90.1%
2008-12-31$2.1 M-37.7%
2007-12-31$3.37 M6.74%
2006-12-31$3.16 M-50.89%
2005-12-31$6.43 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Sarepta Therapeutics
SRPT
$1.25 B 116.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$32.02 B 5,456.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
$24.94 B 4,227.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
$0.68 B 18.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
$0.33 B-41.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$1.83 B 218.39%๐Ÿ‡บ๐Ÿ‡ธ USA